Updates matching "Tobacco Regulation and Products"

WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences. The following is a statement from Lisa Lacasse,

As manufacturers of e-cigarettes and certain other tobacco products face a September 9, 2020, deadline to apply to the U.S. Food and Drug Administration to keep their products on the market, six leading public health and medical organizations today urged the FDA not to authorize the sale of any flavored product

Lincoln, Neb. — Elements of LB632 would block communities from passing their own laws and could hurt the health and well-being of our families, friends and neighbors, warns the American Cancer Society Cancer Action Network (ACS CAN). State laws historically set minimum health, safety, workplace and social standards. Cities and

Setting a dangerous precedent that puts kids and public health at risk, today the U.S. Food and Drug Administration authorized the marketing of Philip Morris’ IQOS heated cigarette as a “modified risk tobacco product” despite the FDA’s acknowledgement that Philip Morris failed to show that IQOS presents a reduced risk of tobacco-related disease...

On July 1, 2020 new measues become law that will protect New Yorkers from some strategies of Big Tobacco that attract people to the dangerous addiction.

SALEM, Ore.— Cancer patients, survivors and their loved ones convened at the State Capitol today, February 27, for the annual Cancer Action Day at the Capitol, hosted by the American Cancer Society Cancer Action Network (ACS CAN). February is National Cancer Prevention Month and the group spent the day-long event

The House Energy and Commerce Subcommittee on Oversight and Investigations holds a hearing on e-cigarette use in the United States amid an ongoing youth tobacco epidemic and one day before the US Food and Drug Administration (FDA) is set to begin enforcement of the agency’s weak guidance released in early January that put industry profits above the health of children.